infection in adult patients with persistent cough Free

Abstract

is a frequent causative agent of acute respiratory disease. To assess whether plays a role in persistent cough, the prevalence of infection in adult patients with persistent cough was investigated. Nasopharyngeal swabs and serology samples from 366 adult patients with a persistent cough lasting in excess of 2 weeks and 106 control subjects were analysed for bacterial isolation and by PCR. was isolated from two patients and from none of the controls and was detected by PCR in 20 patients and one control. Serological evidence of acute infection was present in 24 patients but in none of the controls. Of these 20 patients who were positive by culture and/or PCR, three were still positive by PCR after 2 weeks of treatment with clarithromycin and symptoms either continued or relapsed. However, when patients were treated with clarithromycin for 5–6 weeks, their symptoms disappeared completely and the results of their cultures and/or PCR for became negative. These data suggest that infection may cause persistent cough in adults. Furthermore, these data also indicate that it may be necessary to eradicate the organism when is detected by culture and/or PCR in patients with persistent cough.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.04986-0
2003-03-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/52/3/265.html?itemId=/content/journal/jmm/10.1099/jmm.0.04986-0&mimeType=html&fmt=ahah

References

  1. Birkebœk N. H, Kristiansen M, Seefeldt T, Degn J, Moller A, Heron I, Andersen P. L, Moller J. K, Ostergard L. 1999; Bordetella pertussis infection and chronic cough in adults. Clin Infect Dis 29:1239–1242 [CrossRef]
    [Google Scholar]
  2. Birkebœk N. H, Jensen J. S, Seefeldt T, Degn J, Huniche B, Andersen P. L, Ostergard L. 2000; Chlamydia pneumoniae infection in adults with chronic cough compared with healthy blood donors. Eur Respir J 16:108–111 [CrossRef]
    [Google Scholar]
  3. Block S, Hedrick J, Hammerschlag M. R, Cassell G. H, Craft J. C. 1995; Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J 14:471–477 [CrossRef]
    [Google Scholar]
  4. Dowell S. F, Peeling R. W, Boman J. 11 other authors 2001; Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 33:492–503 [CrossRef]
    [Google Scholar]
  5. Ekman M. R, Grayston J. T, Visakorpi R, Kleemola M, Kuo C. C, Saikku P. 1993; An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis 17:420–425 [CrossRef]
    [Google Scholar]
  6. Falck G, Gnarpe J, Gnarpe H. 1996; Persistent Chlamydia pneumoniae infection in a Swedish family. Scand J Infect Dis 28:271–273 [CrossRef]
    [Google Scholar]
  7. Falck G, Gnarpe J, Gnarpe H. 1997; Prevalence of Chlamydia pneumoniae in healthy children and in children with respiratory tract infections. Pediatr Infect Dis J 16:549–554 [CrossRef]
    [Google Scholar]
  8. Grayston J. T, Campbell L. A, Kuo C. C, Mordhorst C. H, Saikku P, Thom D. H, Wang S. P. 1990; A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 161:618–625 [CrossRef]
    [Google Scholar]
  9. Hallander H. O, Gnarpe J, Gnarpe H, Olin P. 1999; Bordetella pertussis , Bordetella parapertussis , Mycoplasma pneumoniae , Chlamydia pneumoniae and persistent cough in children. Scand J Infect Dis 31:281–286 [CrossRef]
    [Google Scholar]
  10. Hammerschlag M. R, Roblin P. M. 2000a; Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae . Int J Antimicrob Agents 15:149–152 [CrossRef]
    [Google Scholar]
  11. Hammerschlag M. R, Roblin P. M. 2000b; Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae . Antimicrob Agents Chemother 44:1409 [CrossRef]
    [Google Scholar]
  12. Hammerschlag M. R, Chirgwin K, Roblin P. M, Gelling M, Dumornay W, Mandel L, Smith P. 1992; Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 14:178–182 [CrossRef]
    [Google Scholar]
  13. Kaneko K, Yamashiro Y, Maruyama T, Obinata K. 1999; Chlamydia pneumoniae infection in children with persistent cough. Arch Dis Child 80:581–582
    [Google Scholar]
  14. Kuo C. C, Jackson L. A, Campbell L. A, Grayston J. T. 1995; Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8:451–461
    [Google Scholar]
  15. Linnemann C. C Jr, Nasenbeny J. 1977; Pertussis in the adult. Annu Rev Med 28:179–185 [CrossRef]
    [Google Scholar]
  16. Miyashita N, Kubota Y, Kimura M, Nakajima M, Niki Y, Soejima R, Matsumoto A. 1994; Characterization of a Chlamydia pneumoniae strain isolated from a 57-year-old man. Microbiol Immunol 38:857–864 [CrossRef]
    [Google Scholar]
  17. Miyashita N, Matsumoto A, Kubota Y, Nakajima M, Niki Y, Matsushima T. 1996a; Continuous isolation and characterization of Chlamydia pneumoniae from a patient with diffuse panbronchiolitis. Microbiol Immunol 40:547–552 [CrossRef]
    [Google Scholar]
  18. Miyashita N, Matsumoto A, Soejima R, Kubota Y, Kishimoto T, Nakajima M, Niki Y, Matsushima T. 1996b; Evaluation of a direct fluorescent antibody assay for detection of Chlamydia pneumoniae . Jpn J Assoc Infect Dis 70:224–231
    [Google Scholar]
  19. Miyashita N, Niki Y, Kishimoto T, Nakajima M, Matsushima T. 1997; In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp. Antimicrob Agents Chemother 41:1331–1334
    [Google Scholar]
  20. Miyashita N, Fukano H, Niki Y, Matsushima T. 2001a; In vitro activity of telithromycin, a new ketolide, against Chlamydia pneumoniae . J Antimicrob Chemother 48:403–405 [CrossRef]
    [Google Scholar]
  21. Miyashita N, Niki Y, Matsushima T. 2001b; In vitro and in vivo activities of sitafloxacin against Chlamydia spp. Antimicrob Agents Chemother 45:3270–3272 [CrossRef]
    [Google Scholar]
  22. Miyashita N, Niki Y, Nakajima M, Fukano H, Matsushima T. 2001c; Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults. Chest 119:1416–1419 [CrossRef]
    [Google Scholar]
  23. Miyashita N, Fukano H, Hara H, Yoshida K, Niki Y, Matsushima T. 2002; Recurrent pneumonia due to persistent Chlamydia pneumoniae infection. Intern Med 41:30–33 [CrossRef]
    [Google Scholar]
  24. Nennig M. E, Shinefield H. R, Edwards K. M, Black S. B, Fireman B. H. 1996; Prevalence and incidence of adult pertussis in an urban population. JAMA 275:1672–1674 [CrossRef]
    [Google Scholar]
  25. Normann E, Gnarpe J, Gnarpe H, Wettergren B. 1998; Chlamydia pneumoniae in children with acute respiratory tract infections. Acta Paediatr 87:23–27 [CrossRef]
    [Google Scholar]
  26. Poe R. H, Harder R. V, Israel R. H, Kallay M. C. 1989; Chronic persistent cough. Experience in diagnosis and outcome using an anatomic diagnostic protocol. Chest 95:723–728 [CrossRef]
    [Google Scholar]
  27. Robertson P. W, Goldberg H, Jarvie B. H, Smith D. D, Whybin L. R. 1987; Bordetella pertussis infection: a cause of persistent cough in adults. Med J Aust 146:522–525
    [Google Scholar]
  28. Roblin P. M, Hammerschlag M. R. 1998; Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia. Antimicrob Agents Chemother 42:194–196
    [Google Scholar]
  29. Soda K, Kishimoto T, Kubota Y, Matsushima T, Izutsu H, Matsumoto A, Soejima R. 1997; An outbreak of Chlamydia pneumoniae in a junior high school and its district: presence of asymptomatic oropharyngeal carriers in healthy subjects and in cases of pneumonia after a clinical cure. Amakusa Med J 11:17–28 (in Japanese
    [Google Scholar]
  30. Wright S. W, Edwards K. M, Decker M. D, Zeldin M. H. 1995; Pertussis infection in adults with a persistent cough. JAMA 273:1044–1046 [CrossRef]
    [Google Scholar]
  31. Wright S. W, Edwards K. M, Decker M. D, Grayston J. T, Wang S. P. 1997; Prevalence of positive serology for acute Chlamydia pneumoniae infection in emergency department patients with persistent cough. Acad Emerg Med 4:179–183 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.04986-0
Loading
/content/journal/jmm/10.1099/jmm.0.04986-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed